CN111972495A - Children milk powder containing phospholipid group - Google Patents
Children milk powder containing phospholipid group Download PDFInfo
- Publication number
- CN111972495A CN111972495A CN202010862123.1A CN202010862123A CN111972495A CN 111972495 A CN111972495 A CN 111972495A CN 202010862123 A CN202010862123 A CN 202010862123A CN 111972495 A CN111972495 A CN 111972495A
- Authority
- CN
- China
- Prior art keywords
- milk powder
- vitamin
- children
- powder
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a children milk powder containing milk phospholipid group, the main component is at least one of whole milk powder, skim milk powder, condensed milk powder and desalted whey powder, and every 100g of the formula milk powder also contains 11.5-50mg of phosphatidylserine, 3.9-6mg of cephalin, 2.4-4mg of sphingomyelin and 1.1-3.5mg of phosphatidylinositol. The children milk powder can be rapidly absorbed by human body, promote brain development and bone growth of children, and improve immunity of children.
Description
Technical Field
The invention relates to the technical field of children milk powder, in particular to children milk powder containing cephalin groups.
Background
The milk powder is prepared by removing water from animal milk, and is suitable for storage. The milk powder is prepared from fresh milk or goat milk by freezing or heating to remove almost all water in milk, drying, and adding appropriate amount of vitamins and minerals. With the rapid development of milk powder, the requirements on the children milk powder are higher and higher, but the existing children milk powder only has nutrient elements required by the normal development of human bodies and cannot actively promote the development of bones.
The phospholipid is a mixture containing Phosphatidylcholine (PC), Phosphatidylethanolamine (PE), Phosphatidylserine (PS) and Phosphatidylinositol (PI), cephalin, and sphingomyelin as main ingredients. Phosphatidylserine is also called compound nervonic acid. The English name Phosphatidylserine, PS for short, is extracted from natural soybean oil residues. Are active substances of cell membranes, in particular in brain cells. The functional components mainly improve nerve cell function, regulate the conduction of nerve pulse and enhance brain memory function, and the lipophilic components can quickly enter the brain through a blood brain barrier after being absorbed due to strong lipophilicity, thereby playing the roles of relieving blood vessel smooth muscle cells and increasing blood supply of the brain. Cephalin is the main component of nerve cell membrane, regulates all metabolic activities of nerve cells, influences a series of important functions of nerve tissues, and can be directly utilized by human brain by oral administration, so that the nerve cell membrane is repaired, and the normal metabolism of neurons is recovered. Sphingomyelin is a major component of animal cell membranes and other various biological membranes. Sphingomyelin can be hydrolyzed by sphingomyelinase to produce a range of bioactive lipids such as ceramides. Ceramides act as cellular second messengers and produce diverse biological effects in the cardiovascular system. Therefore, the phospholipid added into the children milk powder can be quickly absorbed by human bodies, the brain development and the bone growth of children are promoted, and the immunity of the children can be improved.
Disclosure of Invention
The invention aims to provide the formula milk powder containing the phospholipid group, which aims to promote the brain development and the bone growth of children from the aspect of supplementing nutrition and improve the immunity of the children.
The technical scheme adopted by the invention for solving the problems is as follows: the children's milk powder containing phospholipid group has the main components of whole milk powder and/or defatted milk powder and/or desalted whey powder and/or condensed milk powder, the whole milk powder and/or defatted milk powder and/or desalted whey powder and/or condensed milk powder has the mass percentage content of 95-100%, and the formula milk powder contains 11.5-50mg of phosphatidylserine, 3.9-6mg of cephalin, 2.4-4mg of sphingomyelin and 1.1-3.5mg of phosphatidylinositol in every 100g, and can promote the brain development of children in a long-term and pointed manner.
Every 100g of the milk powder also contains one or more than two of the following components: 10-50mg of immunoglobulin, 0.02-0.1 mug of insulin-like growth factor I, 10.03-0.15 mug of transforming growth factor beta, 20.07-0.35 mug of transforming growth factor beta, 20-100mg of hydrolyzed yolk powder and 10-50mg of colostrum basic protein, and the components can promote the growth of children and improve the immunity of children.
Every 100g of the milk powder also contains one or more than two of the following components: 800 mu g of vitamin A, 5-10 mu g of vitamin D, 2-5mg of vitamin E, 1500-1000 mu g of vitamin B, 6300-500 mu g of vitamin B, 122-4 mu g of vitamin B, 30-60mg of vitamin C, 3-6mg of pantothenic acid, 200 mu g of folic acid, 60-100mg of magnesium, 5-10mg of iron, 6-12mg of zinc, 1000mg of calcium 600-containing material, 400mg of sodium 300-containing material, 8-10mg of docosahexaenoic acid (DHA), 10-20mg of lactoferrin and 300mg of lutein 160-containing material.
The above components can supplement vitamins and microelements required by children, promote health, and promote brain development of children by matching with phospholipid group.
The phospholipid group can be mixed with other milk powder formula components in a powder form, is suitable for various conventional milk powder preparation methods, is convenient to apply, and does not need special operation.
Compared with the prior art, the children milk powder containing phospholipid group has the following advantages and effects: the phospholipid group in the formula milk powder can be directly purchased from the market, has high purity, is suitable to be used as an additive nutrient of special milk powder for children, and can better promote brain development, promote skeleton development and improve immunity in the long-term and targeted supplement process of nutrient substances.
Detailed Description
The invention will be further illustrated by the following detailed description of specific embodiments, which are not to be construed as limiting the invention but are intended to be exemplary only.
The first embodiment is as follows: 40g of whole milk powder, 30g of desalted whey powder, 15g of skimmed milk powder, 10g of condensed milk powder, 11.5mg of phosphatidylserine, 3.9mg of cephalin, 2.4mg of sphingomyelin and 1.1mg of phosphatidylinositol, 10mg of immunoglobulin, 0.02 μ g of para-insulin growth factor I, 10.03 μ g of transforming growth factor beta and 20.07 μ g of transforming growth factor beta, 20mg of yolk hydrolyzed powder, 10mg of colostrum basic protein, 400 μ g of vitamin A, 5 μ g of vitamin D, 2mg of vitamin E, 1500 μ g of vitamin B, 6300 μ g of vitamin B, 122 μ g of vitamin B, 30mg of vitamin C, 3mg of pantothenic acid, 100 μ g of folic acid, 60mg of magnesium, 5mg of iron, 6mg of zinc, 600mg of calcium, 300mg of sodium, 8mg of docosahexaenoic acid (DHA), 10mg of lactoferrin and 160mg of lutein.
Example two: 60g of whole milk powder, 35g of desalted whey powder, 50mg of phosphatidylserine, 6mg of cephalin, 4mg of sphingomyelin, 3.5mg of phosphatidylinositol, 50mg of immunoglobulin, 0.1 μ g of insulin-like growth factor I, 10.15 μ g of transforming growth factor beta and 20.35 μ g of transforming growth factor beta, 100mg of hydrolyzed yolk powder, 50mg of colostrum basic protein, 800 μ g of vitamin A, 10 μ g of vitamin D, 5mg of vitamin E, 11000 μ g of vitamin B, 6500 μ g of vitamin B, 124 μ g of vitamin B, 60mg of vitamin C, 3mg of pantothenic acid, 200 μ g of folic acid, 100mg of magnesium, 10mg of iron, 12mg of zinc, 1000mg of calcium, 400mg of sodium, 10mg of docosahexaenoic acid (DHA), 20mg of lactoferrin and 300mg of lutein.
All equivalent or simple changes made in the principles, methods and processes described herein are intended to be encompassed within the scope of the present invention.
Claims (3)
1. A children milk powder containing milk phospholipid group comprises at least one of whole milk powder, skimmed milk powder, condensed milk powder and desalted whey powder as main components, and is characterized in that: every 100g of the formula milk powder also contains 11.5-50mg of phosphatidylserine, 3.9-6mg of cephalin, 2.4-4mg of sphingomyelin and 1.1-3.5mg of phosphatidylinositol.
2. The milk phospholipid group-containing children's milk powder of claim 1, wherein: every 100g of the milk powder also contains one or more than two of the following components:
10-50mg of immunoglobulin, 0.02-0.1 mug of insulin-like growth factor I, 10.03-0.15 mug of transforming growth factor beta, 20.07-0.35 mug of transforming growth factor beta, 20-100mg of hydrolyzed yolk powder and 10-50mg of colostrum basic protein.
3. The milk phospholipid group-containing children's milk powder of claim 2, wherein: every 100g of the milk powder also contains one or more than two of the following components:
800 mu g of vitamin A, 5-10 mu g of vitamin D, 2-5mg of vitamin E, 1500-1000 mu g of vitamin B, 6300-500 mu g of vitamin B, 122-4 mu g of vitamin B, 30-60mg of vitamin C, 3-6mg of pantothenic acid, 200 mu g of folic acid, 60-100mg of magnesium, 5-10mg of iron, 6-12mg of zinc, 1000mg of calcium 600-containing material, 400mg of sodium 300-containing material, 8-10mg of docosahexaenoic acid (DHA), 10-20mg of lactoferrin and 300mg of lutein 160-containing material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010862123.1A CN111972495A (en) | 2020-08-25 | 2020-08-25 | Children milk powder containing phospholipid group |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010862123.1A CN111972495A (en) | 2020-08-25 | 2020-08-25 | Children milk powder containing phospholipid group |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111972495A true CN111972495A (en) | 2020-11-24 |
Family
ID=73443686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010862123.1A Pending CN111972495A (en) | 2020-08-25 | 2020-08-25 | Children milk powder containing phospholipid group |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111972495A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114208894A (en) * | 2021-11-30 | 2022-03-22 | 内蒙古伊利实业集团股份有限公司 | Formula milk powder containing phospholipid composition and preparation method and application thereof |
| CN115590195A (en) * | 2022-09-26 | 2023-01-13 | 黑龙江飞鹤乳业有限公司（Cn） | Use of phospholipids, nutritional compositions, food products and uses thereof |
| CN117378763A (en) * | 2023-12-12 | 2024-01-12 | 内蒙古伊利实业集团股份有限公司 | Nutritional composition with immunoregulatory function activity and application thereof |
| CN117678639A (en) * | 2024-02-02 | 2024-03-12 | 内蒙古蒙牛乳业（集团）股份有限公司 | Child formula milk added with breast milk oligosaccharide and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106912614A (en) * | 2017-03-10 | 2017-07-04 | 海普诺凯营养品有限公司 | A kind of humanized formula milk and preparation method thereof |
-
2020
- 2020-08-25 CN CN202010862123.1A patent/CN111972495A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106912614A (en) * | 2017-03-10 | 2017-07-04 | 海普诺凯营养品有限公司 | A kind of humanized formula milk and preparation method thereof |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114208894A (en) * | 2021-11-30 | 2022-03-22 | 内蒙古伊利实业集团股份有限公司 | Formula milk powder containing phospholipid composition and preparation method and application thereof |
| CN115590195A (en) * | 2022-09-26 | 2023-01-13 | 黑龙江飞鹤乳业有限公司（Cn） | Use of phospholipids, nutritional compositions, food products and uses thereof |
| CN117378763A (en) * | 2023-12-12 | 2024-01-12 | 内蒙古伊利实业集团股份有限公司 | Nutritional composition with immunoregulatory function activity and application thereof |
| CN117378763B (en) * | 2023-12-12 | 2024-03-26 | 内蒙古伊利实业集团股份有限公司 | Nutritional composition with immunoregulatory function activity and application thereof |
| CN117678639A (en) * | 2024-02-02 | 2024-03-12 | 内蒙古蒙牛乳业（集团）股份有限公司 | Child formula milk added with breast milk oligosaccharide and preparation method thereof |
| CN117678639B (en) * | 2024-02-02 | 2024-05-14 | 内蒙古蒙牛乳业（集团）股份有限公司 | Child formula milk added with breast milk oligosaccharide and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111972495A (en) | Children milk powder containing phospholipid group | |
| EP2073647B2 (en) | Ketogenic diet | |
| CN103079415B (en) | For the alimentation composition stimulating muscle protein to synthesize | |
| CA2436764C (en) | Rehydration composition | |
| EP2342974A2 (en) | Composition for improving membrane composition and functioning of cells | |
| AU2002230270A1 (en) | Rehydration composition | |
| CA2914811C (en) | Muscle preservation in overweight or obese adult during weight loss program | |
| EP3016529B1 (en) | New prophylactic use for prevention of infections | |
| US20090028990A1 (en) | Food composition for stimulating growth comprising fraction isolated from mammalian colostrum or milk whey | |
| CN112998080A (en) | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid | |
| US9056056B2 (en) | Processing for dispersing amino acids | |
| JP2005058017A (en) | Phospholipid-containing composition | |
| GB2522112A (en) | Food compositions | |
| US20130089638A1 (en) | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes | |
| CN115104731B (en) | Nutritional composition and food comprising said nutritional composition | |
| US20160051585A1 (en) | Combined protein supplements | |
| EP3773013A1 (en) | Insulin control in overweight or obese adult during life time intervention |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201124 |
|
| RJ01 | Rejection of invention patent application after publication |